Blood filtration
Total Trials
11
As Lead Sponsor
8
As Collaborator
3
Total Enrollment
858
NCT02914132
Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis
Phase: N/A
Role: Lead Sponsor
Start: Feb 29, 2016
Completion: Jun 7, 2018
NCT04413955
Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA
Role: Collaborator
Start: Jun 1, 2020
Completion: Jan 31, 2022
NCT04260789
Reduction of Pathogen Load From the Blood in Septic Patients With Suspected, Life-threatening Bloodstream Infection
Start: Aug 19, 2020
Completion: Aug 1, 2022
NCT04547257
Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19
Start: May 4, 2021
Completion: Dec 31, 2022
NCT04984902
Reduction of BK Viremia in Kidney Transplant Patients
Start: Feb 1, 2022
Completion: Apr 1, 2023
NCT05011656
Blood Purification for the Treatment of Pathogen Associated Shock
Start: Apr 19, 2024
Completion: Sep 30, 2025
NCT06481397
OSCAR I STUDY - The ONCObind CTC Removal Study
Start: Aug 29, 2024
Completion: Oct 18, 2024
NCT06637800
Prospective, Open-label Study of Seraph 100 in Patients With Prolonged COVID (PC)
Start: Feb 15, 2025
Completion: Apr 30, 2025
NCT06655142
OSCAR II STUDY - The ONCObind CTC Removal Study
Start: Oct 15, 2025
Completion: Jun 30, 2026
Loading map...